DXCM DexCom, Inc.

86.90USD+1.80%Mkt Cap: 32.79B $P/E: 34.48

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States an…

Key Statistics

Company
Market Cap32.79B USD
Enterprise Value31.66B USD
Revenue (TTM)4.97B USD
Gross Profit2.80B USD
Net Income (TTM)836.30M USD
Revenue/Share12.87 USD
Last Price86.90 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)34.48
P/E (Forward)27.34
PEG1.31
EV/EBITDA22.57
EV/Revenue6.37
P/S6.48
P/B12.29
EPS (TTM)2.52
EPS (Forward)3.12
52W Range
54.1185% of range92.59
52W High92.59 USD
52W Low54.11 USD
Profitability
Gross Margin60.10%
Oper. Margin24.33%
EBITDA Margin28.24%
Profit Margin17.94%
ROE30.46%
ROA13.19%
Growth
Revenue Growth13.10%
Earnings Growth43.60%
Cash Flow & Leverage
Operating CF1.44B USD
CapEx (TTM)363.50M USD
FCF Margin20.55%
FCF Yield3.11%
Net Debt-548.60M USD
Net Debt/EBITDA-0.39
Balance Sheet
Debt/Equity0.51
Current Ratio1.73
Quick Ratio1.37
Book Value/Sh6.95 USD
Cash/Share5.16 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split4:1
Split DateJun 13, 2022
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)95.08 USD
Upside (mean)+9.4%
Target Range79.00 USD – 115.00 USD
79.00+9.4% to mean115.00
# Analysts25
Ownership
Shares Out.377.36M
Float376.00M
Insiders0.26%
Institutions106.61%
Short Interest
Short Ratio4.5d
Short % Float5.28%
Short % Out.4.57%
Shares Short17.26M
Short (prev mo.)16.53M
Technical
SMA 5086.38 (+0.6%)
SMA 20073.05 (+19.0%)
Beta1.42
S&P 52W Chg14.58%
Avg Vol (30d)3.93M
Avg Vol (10d)3.37M
Technical Indicators
RSI (14)46.4
MACD0.3042
MACD Signal0.7781
MACD Hist.-0.4739
BB Upper90.91 USD
BB Middle86.82 USD
BB Lower82.72 USD
BB Width9.43%
ATR (14)2.227 USD
Vol Ratio (20d)0.56x